| Model Number |
2800 |
| Medical Device Problem Code |
Gradient Increase (1270)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
| Date of Event |
08/25/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient with a 23mm 2800tfx aortic valve, underwent a valve-in-valve procedure after an implant duration of 5 years, 5 months due to stenosis.The procedure was performed with a non-edwards device.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative: the subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Additional Manufacturer Narrative
|
|
The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction.The most likely cause is patient factors, including history of coronary artery bypass graft (cabg), coronary artery disease (cad), diabetes mellitus (dm) and hyperlipidemia (hld).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a 23mm 2800tfx aortic valve, underwent a valve-in-valve procedure after an implant duration of 5 years, 5 months due to stenosis.The patient presented with heart failure and shortness of breath.The procedure was performed with a non-edwards device.The patient is stable.
|
| |
|
Additional Manufacturer Narrative
|
|
H10: additional manufacturer narrative: updated sections: b5, g3, g6, h2, and h6 (clinical code and type of investigation).
|
| |
|
Search Alerts/Recalls
|